The Improving Diabetes Quality Initiative (iDQI) recently published three new CGM-related quality measures. The article details the measure conceptualization and development process, including literature reviews, public comments, and technical expert panel (TEP) feedback, which informed the measure specifications.

iDQI’s mission is to improve the quality of diabetes care and change the standards of care in an era of new and emerging diabetes technology. iDQI aims to create a multi-stakeholder diabetes community united in advancing evidence-based, high-quality, person-centered, and equitable access to care, technology, and services. As one of its initiatives, iDQI convened a TEP in 2021 to curate a diabetes quality measures portfolio of existing measures and novel measure concepts. The TEP prioritized three concepts for further development:

1. Shared decision making regarding CGM initiation to assess the value of initiating CGM for disease management
2. CGM utilization to address disparities in access and use of CGM
3. Review of CGM data to mitigate clinical inertia, while encouraging collaborative review between clinicians and people with diabetes ongoing management and care plans

Next Steps for Measure Development

Following the publication of the measure specifications, iDQI is now preparing to conduct feasibility testing of these quality measures in a clinical setting to refine the specifications and to better understand evolving standards of care for diabetes technology. The measure development and testing is part of a broader initiative managed by Avalere Health in conjunction with the Association of Diabetes Care & Education Specialists and Beyond Type 1, with support from Abbott Diabetes Care and Dexcom. ​

Learn More

Avalere applies our expertise in stakeholder convenings, real-world evidence generation, learning collaboratives, and diabetes technology to help healthcare stakeholders understand the diabetes landscape to reach their corporate objectives. To learn more about iDQI or how to get involved, connect with us.